New daily pill TIX100 takes first step toward tackling obesity
NCT ID NCT07675590
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This early-stage trial tests whether TIX100, a daily oral pill, is safe and tolerable in healthy adults who are overweight or obese. Over 28 days, participants receive either TIX100 or a placebo, and researchers monitor for side effects and how the drug moves through the body. The goal is to gather initial safety data before larger studies can explore whether TIX100 might help with weight management.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
TIX100
What this could lead to
If safe and well-tolerated, TIX100 could be developed further as a daily oral treatment to help manage weight in people with overweight or obesity.
What could go wrong
This is a very early Phase 1 trial with only 18 healthy volunteers, focused on safety, not weight loss. The drug may not prove effective or could have side effects in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ProSciento, INC
RECRUITINGChula Vista, California, 91911, United States